Anti-TNF antibodies, compositions, methods and uses
US8603778B2 · kind B2 · utility
7Cited by
19References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2012 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Jul 12, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-TNF antibodies comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof, as well as nucleic acids encoding such anti-TNF antibodies, complementary nucleic acids, vectors, host cells, production methods and therapeutic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.